Clinical study on the treatment of non small cell lung cancer with the combination of Shenqi Fuzheng injection and EP chemotherapy
10.3760/cma.j.issn.1008-6706.2016.17.006
- VernacularTitle:参芪扶正注射液联合EP方案治疗非小细胞肺癌临床研究
- Author:
Xiuquan SHI
;
Lijun XU
- Publication Type:Journal Article
- Keywords:
Cancer,non small cell lung;
Antineoplastic combined chemotherepy protocols;
Shenqi Fuzheng injection
- From:
Chinese Journal of Primary Medicine and Pharmacy
2016;23(17):2580-2583
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the therapeutic effect of Shenqi Fuzheng injection combined with EP chemotherapy in the treatment of non small cell lung cancer (NSCLC),and to improve the quality of life and side effects.Methods 60 cases of NSCLC were randomly divided into observation group and control group,30 cases in each group.The two groups were treated with EP,the observation group was treated with Shenqi Fuzheng injection for two courses.The life quality and adverse effects were observed.Results The quality of life of the two groups after treatment was compared,the difference was statistically significant (93.3% vs 70.0%,χ2 =2.83,P <0.05),the quality of life in the observation group was significantly higher than that in the control group.The white blood cell reduction,anemia and liver and kidney function damage between the two groups had statistically significant differences (P =0.011,0.025,0.016),the adverse reaction of the observation group was less than the control group.Conclusion Shenqi Fuzheng injection combined with EP regimen in the treatment of NSCLC can protect bone marrow hematopoietic function and improve the quality of life of patients with NSCLC chemotherapy.It can be used as one mean of Chinese and western treatment for patients with NSCLC in clinical application.
